Stock Performance and Market Context
On 18 May 2026, Integrated Proteins Ltd’s share price opened and traded steadily at Rs.126.85, marking a new 52-week and all-time high. The stock outperformed its sector peers, registering a day gain of 1.97%, while the broader Sensex declined by 1.11%. Over the last 11 consecutive trading days, the stock has delivered a robust 21.8% return, significantly outperforming the solvent extraction segment, which fell by 4.43% on the same day.
In terms of relative performance, Integrated Proteins Ltd has demonstrated exceptional strength across multiple time frames. The stock’s one-week gain stands at 8.42% compared to a 2.12% decline in the Sensex. Over one month, the stock surged 41.21%, while the Sensex dropped 5.21%. The three-month performance is particularly striking, with a 309.85% increase versus an 11.14% fall in the Sensex. Year-to-date, the stock has soared 268.75%, contrasting with the Sensex’s 12.69% decline.
Longer-term returns further highlight the company’s extraordinary growth trajectory. Over one year, Integrated Proteins Ltd’s stock appreciated by 187.64%, while the Sensex fell 9.63%. Over three years, the stock has delivered a staggering 1,106.95% return, vastly outpacing the Sensex’s 21.12% gain. The ten-year performance is even more remarkable, with a 5,827.57% increase compared to the Sensex’s 189.46% rise.
Technical Indicators and Trend Analysis
The technical outlook for Integrated Proteins Ltd remains bullish. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong upward momentum. The current trend shifted to bullish on 27 March 2026 at a price of Rs.71.33, marking a clear departure from the previous sideways movement.
Key technical indicators support this positive trend. The MACD and Bollinger Bands show bullish signals on both weekly and monthly charts, while the Dow Theory also confirms a bullish stance. The RSI indicator presents a bearish signal on the weekly chart but shows no significant signal monthly, suggesting some caution in short-term momentum. The KST indicator is bullish weekly but mildly bearish monthly, indicating mixed momentum over different time horizons.
Immediate support is established at the 52-week low of Rs.20.71, while the stock has surpassed previous resistance levels at Rs.56.86 (100-day moving average) and Rs.106.63 (20-day moving average). The current all-time high at Rs.126.85 represents a far resistance level, now converted into a key support zone for future price action.
Valuation Metrics Reflect Elevated Market Expectations
Integrated Proteins Ltd’s valuation multiples as of 18 May 2026 indicate a premium pricing relative to earnings and book value. The trailing twelve months (TTM) price-to-earnings (P/E) ratio stands at an elevated 705x, reflecting high market expectations despite the company’s modest earnings. The price-to-book value (P/BV) ratio is 11.44x, while the enterprise value to EBITDA and EBIT ratios both stand at 232.80x, signalling a stretched valuation.
The enterprise value to sales ratio is 9.06x, and the EV to capital employed ratio matches the P/BV at 11.44x. Dividend metrics are not applicable, with no dividend yield or payout reported. These valuation figures suggest that investors are pricing in significant growth and operational improvements, despite the company’s current earnings profile.
Quality and Financial Trends
Integrated Proteins Ltd is classified as a below-average quality company based on long-term financial performance metrics. The management risk and capital structure are rated below average, while growth is assessed as average. The company has demonstrated healthy long-term sales growth, with a five-year compound annual growth rate (CAGR) of 92.87%, although EBIT growth over the same period is more modest at 7.26%.
Financial leverage remains low, with an average debt to EBITDA ratio of 0.46 and net debt to equity at zero, indicating a strong balance sheet with negligible debt. The average return on capital employed (ROCE) is negative at -5.14%, and return on equity (ROE) is weak at 1.51%. Interest coverage is also weak, with an average EBIT to interest ratio of -0.05x. The company maintains a tax ratio of 21.43% and has no promoter share pledging, which supports financial stability.
Delivery Volumes and Market Activity
Recent delivery volumes indicate increased investor participation. The one-month delivery volume change is 37.31%, with a one-day delivery change of 51.86% compared to the five-day average. On 15 May 2026, the volume traded was 2.62 thousand shares, consistent with the average daily volume over the previous month. These figures suggest sustained interest in the stock amid its price appreciation.
Summary of Market Capitalisation and Ratings
Integrated Proteins Ltd is categorised as a micro-cap company within the edible oil sector. The MarketsMOJO Mojo Score stands at 44.0, with a current Mojo Grade of Sell, upgraded from a previous Strong Sell rating on 27 March 2026. This change in grading coincides with the stock’s shift to a bullish trend and its strong price performance over recent months.
The stock’s recent gains have outpaced both sector and benchmark indices, reflecting a significant turnaround in market sentiment and company performance. Despite the elevated valuation multiples and below-average quality assessment, the stock’s price momentum and technical indicators remain robust as it reaches this historic peak.
Conclusion
Integrated Proteins Ltd’s stock reaching an all-time high of Rs.126.85 on 18 May 2026 marks a notable achievement in its market journey. The stock’s sustained gains over multiple time frames, combined with bullish technical signals and improved market grading, underscore a period of strong performance. While valuation metrics indicate a premium pricing environment and quality assessments suggest areas for improvement, the company’s remarkable price appreciation and market resilience stand out in the edible oil sector landscape.
